Cargando…

Old Drug, New Delivery Strategy: MMAE Repackaged

Targeting therapy is a concept that has gained significant importance in recent years, especially in oncology. The severe dose-limiting side effects of chemotherapy necessitate the development of novel, efficient and tolerable therapy approaches. In this regard, the prostate specific membrane antige...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lahnif, Hanane, Grus, Tilmann, Salvanou, Evangelia-Alexandra, Deligianni, Elisavet, Stellas, Dimitris, Bouziotis, Penelope, Rösch, Frank
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218109/ https://www.ncbi.nlm.nih.gov/pubmed/37239890 http://dx.doi.org/10.3390/ijms24108543

Ejemplares similares

Hybrid Chelator-Based PSMA Radiopharmaceuticals: Translational Approach
por: Lahnif, Hanane, et al.
Publicado: (2021)

A Proof-of-Concept Study on the Therapeutic Potential of Au Nanoparticles Radiolabeled with the Alpha-Emitter Actinium-225
por: Salvanou, Evangelia-Alexandra, et al.
Publicado: (2020)

Biodistribution of Mesoporous Carbon Nanoparticles via Technetium-99m Radiolabelling after Oral Administration to Mice
por: Mamai, Maria, et al.
Publicado: (2021)

Improvement of the Effectiveness of HER2+ Cancer Therapy by Use of Doxorubicin and Trastuzumab Modified Radioactive Gold Nanoparticles
por: Żelechowska-Matysiak, Kinga, et al.
Publicado: (2023)

Endophthalmitis Outbreak Associated with Repackaged Bevacizumab
por: Edison, Laura S., et al.
Publicado: (2015)

Cost evaluation model to compare in house repackaging, repackaging vendors, and sourcing unit dose medications from manufacturers for oral liquids
por: Kelm, Matthew
Publicado: (2022)

Preliminary Evaluation of Iron Oxide Nanoparticles Radiolabeled with (68)Ga and (177)Lu as Potential Theranostic Agents
por: Salvanou, Evangelia-Alexandra, et al.
Publicado: (2022)

Stability of erythropoietin repackaging in polypropylene syringes for clinical use
por: Marsili, Angela, et al.
Publicado: (2017)

Bivalent EGFR-Targeting DARPin-MMAE Conjugates
por: Karsten, Lennard, et al.
Publicado: (2022)

Repackaging mental health programs in low- and middle-income countries
por: Jacob, K. S.
Publicado: (2011)

The sterility, stability and efficacy of repackaged ziv-aflibercept for intravitreal administration
por: Juhong, Jakkrit, et al.
Publicado: (2022)

Discovery of New 1,4,6-Trisubstituted-1H-pyrazolo[3,4-b]pyridines with Anti-Tumor Efficacy in Mouse Model of Breast Cancer †
por: Georgiou, Maria, et al.
Publicado: (2023)

Addressing varenicline adherence through repackaging in a dose administration aid
por: Drovandi, Aaron D, et al.
Publicado: (2017)

Vial-splitting and Repackaging into Aliquot-specific Syringes: A Cost-effective and Waste-decreasing Strategy for Sugammadex
por: Amaya, Sebastian, et al.
Publicado: (2023)

Guanidine-modified albumin-MMAE conjugates with enhanced endocytosis ability
por: Yi, Ce, et al.
Publicado: (2023)

Chelator-Free/Chelator-Mediated Radiolabeling of Colloidally Stabilized Iron Oxide Nanoparticles for Biomedical Imaging
por: Papadopoulou, Sofia, et al.
Publicado: (2021)

Synthesis and In Vitro Evaluation of Gold Nanoparticles Functionalized with Thiol Ligands for Robust Radiolabeling with (99m)Tc
por: Apostolopoulou, Adamantia, et al.
Publicado: (2021)

Telmisartan Tablets Repackaged into Dose Administration Aids: Physicochemical Stability under Tropical Conditions
por: Ma, Anthony P., et al.
Publicado: (2022)

Investigating the physical stability of repackaged medicines stored into commercially available multicompartment compliance aids (MCAs)
por: Raimi‐Abraham, Bahijja Tolulope, et al.
Publicado: (2017)

Stability of medicines after repackaging into multicompartment compliance aids: eight criteria for detection of visual alteration
por: Albert, Valerie, et al.
Publicado: (2017)

Antitumor effect of antitissue factor antibody‐MMAE conjugate in human pancreatic tumor xenografts
por: Koga, Yoshikatsu, et al.
Publicado: (2015)

Whole-Body Pharmacokinetics and Physiologically Based Pharmacokinetic Model for Monomethyl Auristatin E (MMAE)
por: Chang, Hsuan Ping, et al.
Publicado: (2021)

Tumor-Specific Monomethyl Auristatin E (MMAE) Prodrug Nanoparticles for Safe and Effective Chemotherapy
por: Cho, Hanhee, et al.
Publicado: (2022)

FGF2-Derived PeptibodyF2-MMAE Conjugate for Targeted Delivery of Cytotoxic Drugs into Cancer Cells Overexpressing FGFR1
por: Jendryczko, Karolina, et al.
Publicado: (2020)

Monoclonal antibody 4C5 prevents activation of MMP2 and MMP9 by disrupting their interaction with extracellular HSP90 and inhibits formation of metastatic breast cancer cell deposits
por: Stellas, Dimitris, et al.
Publicado: (2010)

Novel Silyl Ether-Based Acid-Cleavable Antibody-MMAE Conjugates with Appropriate Stability and Efficacy
por: Wang, Yanming, et al.
Publicado: (2019)

Time-Prolonged Release of Tumor-Targeted Protein–MMAE Nanoconjugates from Implantable Hybrid Materials
por: Serna, Naroa, et al.
Publicado: (2022)

Repackaging of Malfunctioning High-flow Nasal Cannula as a Rescue Oxygen Therapy: An Innovation amid COVID-19 Crisis
por: Kumar, Amarjeet, et al.
Publicado: (2021)

Enzyme-linked immunosorbent assays for quantification of MMAE-conjugated ADCs and total antibodies in cynomolgus monkey sera
por: Pei, Min, et al.
Publicado: (2022)

Initial in vitro and in vivo assessment of Au@DTDTPA-RGD nanoparticles for Gd-MRI and 68Ga-PET dual modality imaging
por: Tsoukalas, Charalmpos, et al.
Publicado: (2015)

Innovative multimodal DOTA/NODA nanoparticles for MRI and PET imaging for tumor detection
por: Truillet, Charles, et al.
Publicado: (2014)

Antibody-Drug Conjugate Using Ionized Cys-Linker-MMAE as the Potent Payload Shows Optimal Therapeutic Safety
por: Wang, Yanming, et al.
Publicado: (2020)

New insight on the structural features of the cytotoxic auristatins MMAE and MMAF revealed by combined NMR spectroscopy and quantum chemical modelling
por: Johansson, Mikael P., et al.
Publicado: (2017)

An EGFR‐targeting antibody–drug conjugate LR004‐VC‐MMAE: potential in esophageal squamous cell carcinoma and other malignancies
por: Hu, Xin‐yue, et al.
Publicado: (2018)

Anti-tumor efficacy of an MMAE-conjugated antibody targeting cell surface TACE/ADAM17-cleaved Amphiregulin in breast cancer
por: Lofgren, Kristopher A, et al.
Publicado: (2021)

Therapeutic efficacy of a MMAE-based anti-DR5 drug conjugate Oba01 in preclinical models of pancreatic cancer
por: Zheng, Chao, et al.
Publicado: (2023)

Clinical pharmacology of vc-MMAE antibody–drug conjugates in cancer patients: learning from eight first-in-human Phase 1 studies
por: Li, Chunze, et al.
Publicado: (2019)

Optimizing the enzymatic release of MMAE from isoDGR-based small molecule drug conjugate by incorporation of a GPLG-PABC enzymatically cleavable linker
por: Zambra, Marco, et al.
Publicado: (2023)

Therapeutic efficacy, pharmacokinetic profiles, and toxicological activities of humanized antibody-drug conjugate Zt/g4-MMAE targeting RON receptor tyrosine kinase for cancer therapy
por: Yao, Hang-Ping, et al.
Publicado: (2019)

A HER2-targeting antibody-MMAE conjugate RC48 sensitizes immunotherapy in HER2-positive colon cancer by triggering the cGAS-STING pathway
por: Wu, Xiaohan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jecf4rr0n6lqc5n18utu1d9akr